Skip to content
OmniLead
Start free

Active biotechnology investors in New York — 2026

682 investors backed 21 biotechnology offerings by companies in New York in the last 12 months, per SEC Form D. Companies file a Form D with the SEC when they raise money under Regulation D, and report how many investors have already put money in. Funds file one too when they raise, which is how we list the venture and private equity funds based in New York. Figures come straight from SEC EDGAR and refresh daily.

Investors in these offerings
682
Form D “total number already invested” · All 21 offerings, Sep 28, 2025 – Sep 28, 2026
New biotechnology offerings
21
Companies in New York that filed a new Form D, Sep 28, 2025 – Sep 28, 2026
Amount sold
$303.0M
As reported in Form D · All 21 offerings, Sep 28, 2025 – Sep 28, 2026

Offerings are matched on the Form D industry group (Biotechnology) and the company’s business address, one offering per company, funds excluded. Each filing reports how many investors have already invested, not who they are, so an investor in two offerings counts twice. Run the same search on sec.gov.

Venture and private equity funds based in New York

SEC EDGAR Form D filings

Funds file a Form D when they raise from their own investors. These are recent filings by venture capital and private equity funds with a business address in New York, from the last 6 days, newest first.

Recent Form D filings by venture capital and private equity funds in New York
FundTypeCityFund sizeFiledFiling
Collection Co-Investment I Offshore Fund, Ltd.Private equity fundNEW YORKIndefiniteSep 28, 2026 · amendmentForm Dfor Collection Co-Investment I Offshore Fund, Ltd. on sec.gov
Infinedi Phoenix CV, LPPrivate equity fundNEW YORKIndefiniteSep 28, 2026Form Dfor Infinedi Phoenix CV, LP on sec.gov
HPC Co-Invest (I), L.P.Private equity fundNEW YORKIndefiniteSep 28, 2026Form Dfor HPC Co-Invest (I), L.P. on sec.gov
Declaration Partners Real Estate Fund III LPPrivate equity fundNEW YORKIndefiniteSep 28, 2026Form Dfor Declaration Partners Real Estate Fund III LP on sec.gov
Declaration Partners Real Estate Fund III-A LPPrivate equity fundNEW YORKIndefiniteSep 28, 2026Form Dfor Declaration Partners Real Estate Fund III-A LP on sec.gov
ABG Tech Opportunities Fund I, LPVenture capital fundNEW YORKIndefiniteSep 25, 2026Form Dfor ABG Tech Opportunities Fund I, LP on sec.gov
Aisenberg Ventures, a Series of Decile Start Fund, LPVenture capital fundNEW YORK$160.0KSep 25, 2026Form Dfor Aisenberg Ventures, a Series of Decile Start Fund, LP on sec.gov
Mordecai Seed, a Series of Decile Start Fund, LPVenture capital fundNEW YORK$130.0KSep 25, 2026Form Dfor Mordecai Seed, a Series of Decile Start Fund, LP on sec.gov
Vessel Capital Partners Kraken, LLC Series CPrivate equity fundSTATEN ISLAND$6.2MSep 25, 2026 · amendmentForm Dfor Vessel Capital Partners Kraken, LLC Series C on sec.gov
Trimontium Capital Solutions Access Fund LPPrivate equity fundNEW YORKIndefiniteSep 25, 2026Form Dfor Trimontium Capital Solutions Access Fund LP on sec.gov
IEQ Capital Access Fund - South Street Partners GP Fund II, L.P.Private equity fundNEW YORKIndefiniteSep 25, 2026 · amendmentForm Dfor IEQ Capital Access Fund - South Street Partners GP Fund II, L.P. on sec.gov
GP Solutions SPV I LPPrivate equity fundNEW YORKIndefiniteSep 25, 2026Form Dfor GP Solutions SPV I LP on sec.gov

Funds with “Bio”, “Biotech”, “Biotechnology”, “Bioscience” in their name

Form D doesn’t say what a fund invests in, so this is a keyword match on the fund’s name, not a stated biotechnology focus. Venture capital and private equity funds in New York that filed in the last 12 months.

Funds in New York with a biotechnology keyword in their name
FundTypeCityFund sizeFiledFiling
270 Life Sciences Private Capital Fund II (Cayman) LPLife sciencesVenture capital fundNEW YORKIndefiniteSep 16, 2026Form Dfor 270 Life Sciences Private Capital Fund II (Cayman) LP on sec.gov
270 Life Sciences Private Capital Fund II (US) LPLife sciencesVenture capital fundNEW YORKIndefiniteSep 16, 2026Form Dfor 270 Life Sciences Private Capital Fund II (US) LP on sec.gov
Octagon Biotech Opportunities Offshore Fund II LPBiotechPrivate equity fundNEW YORK$175.0MJul 2, 2026Form Dfor Octagon Biotech Opportunities Offshore Fund II LP on sec.gov
Octagon Biotech Opportunities Fund II LPBiotechPrivate equity fundNEW YORK$175.0MJul 2, 2026Form Dfor Octagon Biotech Opportunities Fund II LP on sec.gov
Mirae Asset Capital Life Science Inception I, LPLife scienceVenture capital fundNEW YORK$51.0MMay 11, 2026Form Dfor Mirae Asset Capital Life Science Inception I, LP on sec.gov

Organisation-level public data from SEC EDGAR. We don’t publish personal names or contact details on this page. Fund size is the offering amount in the fund’s Form D; “Indefinite” means the filing didn’t state one.

In OmniLead

From fund filings to the people who run the funds.

The Investors lens lists funds from their Form D filings with fund type, fund size and last filing date, plus the executive officers and managing members each filing names. Contacts come from the fund’s own website, with the source on every row.

Start freeTry the investor lookup

Raising in New York? Find investors who fit.

Search investors built from SEC Form D filings, see why each one matches your round, and reach them from your own inbox.

Start freeSee pricing